Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial With Aconite Pain Oil in Oncological Patients Undergoing Chemotherapy to Prevent Chemotherapy-induced Polyneuropathy (CIPN), to Reduce Symptoms Typical of CIPN and to Improve the Quality of Life of Patients With CIPN

NCT06186479 is registered in ClinicalTrials.gov with WALA Heilmittel GmbH as lead sponsor.

NCT NCT06186479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06186479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial With Aconite Pain Oil in Oncological Patients Undergoing Chemotherapy to Prevent Chemotherapy-induced Polyneuropathy (CIPN), to Reduce Symptoms Typical of CIPN and to Improve the Quality of Life of Patients With CIPN
Lead sponsor
WALA Heilmittel GmbH
Phase
Phase 3
Overall status
Recruiting
Start date
March 13, 2024
Completion date
September 1, 2027
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced polyneuropathy